Remove 2019 Remove Diabetes Remove Hospital Remove Individual
article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. Methods The study included individuals aged 75 to 90 years, diagnosed with diabetes or hypertension, who were treated with at least one antihypertensive, or antidiabetic medication in 2017.

article thumbnail

Outcomes associated with timing of screening for gestational diabetes [Women's health]

Annals of Family Medicine

Context: Screening for gestational diabetes (GDM) at recommended times, based on a pregnant woman’s risk for GDM, is important in order to initiate and optimize the management of GDM as early as possible, thus mitigating the risk of several adverse outcomes for both pregnant women and their offspring.

Screening 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health and Mood Benefits of Semaglutide in HF

Physician's Weekly

Researchers examined the effects of semaglutide on body weight, health status, and mood over 1 year in individuals with HF and obesity. They assessed 122 individuals with HF and obesity who were treated consecutively with semaglutide between January 2019 and August 2023.

article thumbnail

Preemies receive sucrose for pain relief—new research shows it doesn't stop long-term impacts on development

Medical Xpress

As is the case internationally, sucrose is used widely in New Zealand, but there is considerable variation in protocols of use across hospitals. However, we do not guarantee individual replies due to the high volume of messages. No national guidelines for best practice exist. Whats more, pain isnt always managed.

IT 59
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Drug Price Negotiation to Benefit Medicare and Commercial Plans. Other legislative proposals included improving supply chain transparency.